Protection of non-murine mammals against encephalomyocarditis virus using a genetically engineered Mengo virus

Vaccine

Volumn 14, Issue 2, 1996, Pages 155-161

  Osorio, Jorge E ^a   Hubbard, Gene B ^b   Soike, Kenneth F ^c   Girard, Marc ^d   Van Der Werf, Sylvie ^d   Moulin, Jean Claude ^e   Palmenberg, Ann C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d INSTITUT PASTEUR   (France)

^e Pasteur Merieux Serums et Vaccins   (France)

Author keywords

Attenuated EMCV vaccine; Genetically engineered mutant; Mengo virus

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BABOON; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; GENETIC ENGINEERING; HOST RESISTANCE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MENGO VIRUS; MONKEY; NONHUMAN; PRIORITY JOURNAL; SWINE;

EID: 0030051829     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00129-O     Document Type: Article

References (24)

1. Zimmerman, J.J. Encephalomyocarditis. In: Handbook of Zoonoses, Section B: Viral (Ed. Beran, G.W.). CRC Press, Boca Raton, FL, 1994, pp. 423-436
2. Pope, J.H. A virus of the encephalomyocarditis group from a water rat, Hydromys chrysogaster, in North Queensland. Austr. J. Exp. Biol. Med. Sci. 1959, 37, 117-124
3. Matsuzaki, H., Doi, K., Doi, C., Onodera, T. and Mitsuoka, T. Susceptibility of four species of small rodents to encephalomyocarditis (EMC) virus infection. Jikken Dobutsu 1989, 4, 357-361
4. Kissling, R.E., Vanella, J.M. and Schaeffer, M. Recent isolations of encephalomyocarditis virus. Proc. Soc. Exp. Biol. Med. 1956, 91, 148-152
5. Wells, S.K., Gutter, A.E., Soike, K.F. and Baskin, G.B. Encephalomyocarditis virus: epizootic in a zoological collection. J. Zoo Wildl. Med. 1989, 20, 291-296
6. Roca-Garcia, M. and Sanmartin-Barberi, C. The isolation of encephalomyocarditis virus from aotus monkeys. Am. J. Trop. Med. 1957, 6, 840-852
7. Helwig, F.C. and Schmidt, E.C.H. A filter passing agent producing interstitial myocarditis in arthropoid apes and small animals. Science 1945, 102, 31-33
8. Seaman, J.T., Boulton, J.G. and Carrigan, M.J. Encephalomyocarditis virus disease of pigs associated with a plague of rodents. Aust. Vet. J. 1986, 63, 292-294
9. Gainer, J.H. and Murchison, T.E. Encephalomyocarditis virus infection of swine. Vet Med. 1961, 56, 173-175
10. Gainer, J.H. Encephalomyocarditis virus infections in Florida, 1960-1966. JAVMA 1967, 151, 421-425
11. Guthke, R., Veckenstedt, A., Guttner, J., Stracke, R. and Bergter, F. Dynamic model of the pathogenesis of Mengo virus infection in mice. Acta Virol. 1987, 31, 307-320
12. Hubbard, G.B., Soike, K.F., Butler, T.M. et al. An encephalomyocarditis virus epizootic in a baboon colony. Lab. Anim. Sci. 1992, 42, 233-239
13. Brown, F. Prospects for a synthetic Foot-and-Mouth Disease Vaccine. In: Concepts in Viral Pathogenesis II (Eds Notkins, A.L. and Oldstone, M.B.A.). Springer, New York, 1986, pp. 394-400
14. Wesslen, T. and Dinter, Z. The inactivation of foot-and-mouth disease virus by formalin. Arch. Ges. Virusf. 1957, 7, 394-401
15. Graves, J.H. Formaldehyde inactivation of foot-and-mouth disease virus as applied to vaccine preparation. Am. J. Vet. Res. 1963, 24, 1131-1135
16. Wesslen, T., Lycke, E., Gard, S. and Olin, G. Inactivation of poliomyelitis virus by formaldehyde. Arch. Ges. Virusf. 1957, 7, 125-135
17. Duke, G.M. and Palmenberg, A.C. Cloning and synthesis of infectious cardiovirus RNAs containing short, discrete poly(C) tracts. J. Virol. 1989, 63, 1822-1826
18. Duke, G.M., Osorio, J.E. and Palmenberg, A.C. Attenuation of Mengovirus through genetic engineering of the 5′ noncoding poly(C) tract. Nature 1990, 343, 474-476
19. Duke, G.M., Hoffman, M.A. and Palmenberg, A.C. Sequence and structural elements that contribute to efficient encephalomyocarditis viral RNA translation. J. Virol. 1992, 66, 1602-1609
20. Rueckert, R.R. and Pallansch, M.A. Preparation and characterization of encephalomyocarditis virus. Meth. Enzymol. 1981, 780, 315-325
21. Sherry, B., Mosser, A.G., Colonno, R.J. and Rueckert, R.R. Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14. J. Virol. 1986, 57, 246-257
22. Altmeyer, R., Escriou, N., Girard, M., Palmenberg, A.C. and van der Werf, S. Attenuated Mengo virus as a vector for immunogenic human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 1994, 91, 9775-9779
23. Brown, F. Towards a molecular vaccine for foot-and-mouth disease. In: Molecular Aspects of Picornavirus Infection and Detection (Eds Semler, B.L. and Ehrenfeld, E.). American Society for Microbiology, Washington, DC, 1989, pp. 179-191
24. Palmenberg, A.C. and Osorio, J.E. Cardioviral poly(C) tracts and viral pathogenesis. Archs Virol. 1994, 90, 67-77